Evidence map›Paper›PMID 36799341›Full record

ArticleJournal of magnetic resonance imaging : JMRI2023

Implementable Deep Learning for Multi-sequence Proton MRI Lung Segmentation: A Multi-center, Multi-vendor, and Multi-disease Study.

Joshua R Astley, Alberto M Biancardi, Paul J C Hughes, Helen Marshall, Guilhem J Collier, Ho-Fung Chan, Laura C Saunders, Laurie J Smith, Martin L Brook, Roger Thompson and 17 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 7 institutions in 1 country.

Joshua R AstleyPOLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.ORCID 0000-0002-6552-5436
Alberto M BiancardiPOLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
Paul J C HughesPOLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.ORCID 0000-0002-7979-5840
Helen MarshallPOLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.ORCID 0000-0002-7425-1449
Guilhem J CollierPOLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
Ho-Fung ChanPOLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.ORCID 0000-0002-5382-2097
Laura C SaundersPOLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.ORCID 0000-0002-1080-9861
Laurie J SmithPOLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
Martin L BrookPOLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
Roger ThompsonSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.ORCID 0000-0002-0717-4551
Sarah Rowland-JonesSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Sarah SkeochRoyal National Hospital for Rheumatic Diseases, Royal United Hospital NHS Foundation Trust, Bath, UK.
Stephen M BianchiSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Matthew Q HattonSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Najib M RahmanDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, UK.
Ling-Pei HoMRC Human Immunology Unit, University of Oxford, Oxford, UK.
Chris E BrightlingThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Louise V WainThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Amisha SingapuriThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Rachael A EvansUniversity Hospitals of Leicester NHS Trust, University of Leicester, Leicester, UK.
Alastair J MossThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Gerry P McCannThe Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Stefan NeubauerDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, UK.
Betty RamanDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, UK.ORCID 0000-0002-1239-9608
C-MORE/PHOSP-COVID Collaborative Group
Jim M WildPOLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.ORCID 0000-0002-7246-8660
Bilal A TahirPOLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.ORCID 0000-0003-0531-3519
University of Sheffield · GBUniversity of Leicester · GBSheffield Teaching Hospitals NHS Foundation Trust · GBInsigneo · GBNational Institute for Health Research · GBRoyal National Hospital for Rheumatic Diseases · GBUniversity of Oxford · GB

Funding

British Heart Foundation FS/18/13/33281British Heart Foundation RE/18/3/34214British Heart Foundation SP/14/6/31350Department of Health COV0319Department of Health NIHR-RP-2017-ST2-08-007Department of Health NIHR-RP-R3-12-027Medical Research Council MR/M008894/1Medical Research Council MR/V027859/1
6 · The paper itself

Abstract

backgroundRecently, deep learning via convolutional neural networks (CNNs) has largely superseded conventional methods for proton ( PURPOSE: Develop a generalizable CNN for lung segmentation in STUDY TYPE: Retrospective. POPULATION: A total of 809 FIELD STRENGTH/SEQUENCE: 1.5-T and 3-T/3D spoiled-gradient recalled and ultrashort echo-time ASSESSMENT: 2D and 3D CNNs, trained on single-center, multi-sequence data, and the conventional spatial fuzzy c-means (SFCM) method were compared to manually delineated expert segmentations. Each method was validated on external data originating from several centers. Dice similarity coefficient (DSC), average boundary Hausdorff distance (Average HD), and relative error (XOR) metrics to assess segmentation performance. STATISTICAL TESTS: Kruskal-Wallis tests assessed significances of differences between acquisitions in the testing set. Friedman tests with post hoc multiple comparisons assessed differences between the 2D CNN, 3D CNN, and SFCM. Bland-Altman analyses assessed agreement with manually derived lung volumes. A P value of <0.05 was considered statistically significant.

resultsThe 3D CNN significantly outperformed its 2D analog and SFCM, yielding a median (range) DSC of 0.961 (0.880-0.987), Average HD of 1.63 mm (0.65-5.45) and XOR of 0.079 (0.025-0.240) on the testing set and a DSC of 0.973 (0.866-0.987), Average HD of 1.11 mm (0.47-8.13) and XOR of 0.054 (0.026-0.255) on external validation data. DATA

conclusionThe 3D CNN generated accurate EVIDENCE LEVEL: 4. TECHNICAL EFFICACY: Stage 1.

Indexed as

Deep LearningFemaleHumansImage Processing, Computer-AssistedLungMagnetic Resonance ImagingMaleProtonsRetrospective StudiesProtonsCNNdeep learninglungsegmentation

Identifiers

PMID36799341
PMCPMC10946727
OpenAlexW4321166513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.